Autologous stem cells for the treatment of post-mastectomy lymphedema: A pilot study

Cytotherapy

Volumn 13, Issue 10, 2011, Pages 1249-1255

  Maldonado, Gerardo Enrique Muñoz ^a   Pérez, Carlos Alberto Alvarez ^a   Covarrubias, Eli Esaú Aguiñaga ^a   Cabriales, Sylvia Aide Martínez ^a   Leyva, Laura Alvarado ^a   Pérez, José Carlos Jaime ^a   Almaguer, David Gómez ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

autologous; lymphedema; mastectomy; stem cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ABDUCTION; ADULT; ARM CIRCUMFERENCE; ARM EXERCISE; ARM MOVEMENT; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CD34 SELECTION; CELLULITIS; CLINICAL ARTICLE; COMORBIDITY; COMPARATIVE EFFECTIVENESS; COMPRESSION GARMENT; COMPRESSION THERAPY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; LYMPHEDEMA; MANUAL LABOR; MASSAGE; MASTECTOMY; MEDICAL HISTORY; PAIN; PAIN ASSESSMENT; PATIENT MOBILITY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RECURRENT INFECTION; SENSORY DYSFUNCTION; STEM CELL MOBILIZATION; THERAPY EFFECT; TREATMENT DURATION;

EID: 80054738336     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.594791     Document Type: Article

References (35)

1. Thomas-MacLean R, Miedema B, Tatemichi SR. Breast cancer-related lymphedema: Women ' s experiences with an underestimated condition. Can Fam Physician. 2005;51:246-7.
2. Purushotham AD, Bennett Britton TM, Klevesath MB, Chou P, Agbaje OF, Duffy SW. Lymph node status and breast cancer-related lymphedema. Ann Surg. 2007;246:42-5. (Pubitemid 47012205)
3. Bumpers HL, Best IM, Norman D, Weaver WL. Debilitating lymphedema of the upper extremity after treatment of breast cancer. Am J Clin Oncol. 2002;25:365-7. (Pubitemid 34864030)
4. Harris SR, Hugi MR, Olivotto IA, Levine M. Clinical practice guidelines for the care and treatment of breast cancer. II. Lymphedema. CMAJ. 2001;164(2):191-9. (Pubitemid 32157741)
5. Soran A, Wu WC, Dirican A, Johnson R, Andacoglu O, Wilson J. Estimating the probability of lymphedema after breast cancer surgery. Am J Clin Oncol. 2010.
6. Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, et al. Risk factors for lymphedema in a prospective breast cancer survivorship study: The Pathways Study. Arch Surg. 2010;145:1055-63.
7. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580-4. (Pubitemid 16013418)
8. Quirion E. Recognizing and treating upper extremity lymphedema in postmastectomy/lumpectomy patients: A guide for primary care providers. J Am Acad Nurse Pract. 2010;22: 450-9.
9. Jain MS, Danoff JV, Paul SM. Correlation between bioelectrical spectroscopy and perometry in assessment of upper extremity swelling. Lymphology. 2010;43:85-94.
10. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83:2776-81. (Pubitemid 29024266)
11. Scavelli C, Weber E, Agliano M, Cirulli T, Nico B, Vacca A, et al. Lymphatics at the crossroads of angiogenesis and lymphangiogenesis. J Anat. 2004;204:433-49. (Pubitemid 38807808)
12. Partsch H, Stout N, Forner-Cordero I, Flour M, Moffatt C, Szuba A, et al. Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group. Int Angiol. 2010;29:442-53.
13. Micke O, Schomburg L, Buentzel J, Kisters K, Muecke R. Selenium in oncology: From chemistry to clinics. Molecules. 2009;14:3975-88.
14. Farinola N, Piller N. Pharmacogenomics: Its role in re-establishing coumarin as treatment for lymphedema. Lymphat Res Biol. 2005;3:81-6. (Pubitemid 41386630)
15. de Fatima Guerreiro Godoy M, Oliani AH, Pereira de Godoy JM. Active exercises utilizing a facilitating device in the treatment of lymphedema resulting from breast cancer therapy. Ger Med Sci. 2010;1-4.
16. Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL. Arm edema in breast cancer patients. J Natl Cancer Inst. 2001;93:96-111. (Pubitemid 32111987)
17. Kim do S, Sim YJ, Jeong HJ, Kim GC. Effect of active resistive exercise on breast cancer-related lymphedema: A randomized controlled trial. Arch Phys Med Rehabil. 2010;91:1844 - 8.
18. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: Results from a randomized controlled trial. J Clin Oncol. 2005;23:4312-21. (Pubitemid 46209968)
19. Sagar J, Chaib B, Sales K, Winslet M, Seifalian A. Role of stem cells in cancer therapy and cancer stem cells: A review. Cancer Cell Int. 2007;7:9.
20. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7. (Pubitemid 27087709)
21. Huang P, Li S, Han M, Xiao Z, Yang R, Han ZC. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care. 2005;28:2155-60. (Pubitemid 41242461)
22. Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation. 2009;119:281-9.
23. Religa P, Cao R, Bjorndahl M, Zhou Z, Zhu Z, Cao Y. Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood. 2005;106:4184-90. (Pubitemid 41775925)
24. Rutkowski JM, Boardman KC, Swartz MA. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol. 2006;291:H1402 - 10. (Pubitemid 44343687)
25. Kim H, Dumont DJ. Molecular mechanisms in lymphangiogenesis: Model systems and implications in human disease. Clin Genet. 2003;64:282-92. (Pubitemid 37236128)
26. Laco F, Grant MH, Flint DJ, Black RA. Cellular transdifferentiation and morphogenesis toward the lymphatic lineage in regenerative medicine. Stem Cells Dev. 2011;20(2): 181-95.
27. Sitzia J. Volume measurement in lymphoedema treatment: Examination of formulae. Eur J Cancer Care (Engl). 1995; 4:11-6.
28. Karges JR, Mark BE, Stikeleather SJ, Worrell TW. Concurrent validity of upper-extremity volume estimates: Comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther. 2003;83:134-45. (Pubitemid 36169384)
29. Engler HS, Sweat RD. Volumetric arm measurements: Technique and results. Am Surg. 1962;28:465-8.
30. Casley-Smith JR. Measuring and representing peripheral oedema and its alterations. Lymphology. 1994;27:56-70. (Pubitemid 24194082)
31. Sander AP, Hajer NM, Hemenway K, Miller AC. Upperextremity volume measurements in women with lymphedema: A comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther. 2002;82:1201-12. (Pubitemid 35425213)
32. Farrar JT, Young JP Jr., LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-58. (Pubitemid 33016608)
33. Turk DC, Rudy TE, Sorkin BA. Neglected topics in chronic pain treatment outcome studies: Determination of success. Pain. 1993;53:3-16. (Pubitemid 23137261)
34. Farrar JT, Pritchett YL, Robinson M, Prakash A, Chappell A. The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: Analyses of data from clinical trials of duloxetine in pain disorders. J Pain. 2010;11:109-18.
35. Hou C, Wu X, Jin X. Autologous bone marrow stromal cell transplantation for the treatment of secondary arm lymphedema: A prospective controlled study in patients with breast cancer related lymphedema. Jpn J Clin Oncol. 2008;38: 670-4.